Induction of regulatory dendritic cells by dexamethasone and 1α,25-Dihydroxyvitamin D3
Authors:
- Anders Elm PedersenAPAnders Elm Pedersen
- Monika GadMGMonika Gad
- Mark R. WalterMWMark R. Walter
- Mogens Helweg ClaessonMCMogens Helweg Claesson
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 91 (1) , 63-69
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4Nature Immunology, 2002
- A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cellsSeminars in Immunology, 2000
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytesImmunology, 1998
- Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.Journal of Clinical Investigation, 1998
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNF‐α, but strongly enhanced by interleukin‐10European Journal of Immunology, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987